Subcutaneous Drug Delivery Devices Market Forecasted to Reach $36.89 Billion At a CAGR of 7.5%. By 2028

The Business Research Company’s Early Year-End Sale! Get up to 30% off detailed market research reports—for a limited time only!

LONDON, GREATER LONDON, UNITED KINGDOM, December 17, 2024 /EINPresswire.com/ -- The Business Research Company’s Early Year-End Sale! Get up to 30% off detailed market research reports—limited time only!

The subcutaneous drug delivery devices market is on an upward trajectory, driven by an increase in chronic diseases and a preference for self-administration of drugs. The market, which was valued at $25.78 billion in 2023, is projected to grow to $27.66 billion in 2024, at a compound annual growth rate CAGR of 7.3%. Key drivers behind this growth include the rise in diabetes and obesity rates, patient preference for convenient treatments, and an aging population.

For a more detailed insight into the subcutaneous drug delivery devices market, request a sample report: https://www.thebusinessresearchcompany.com/sample.aspx?id=19723&type=smp

What Factors Drive Growth in the Subcutaneous Drug Delivery Devices Market?

The subcutaneous drug delivery devices market is predicted to accelerate its growth in the next few years, projected to reach $36.89 billion in 2028, growing at a CAGR of 7.5%. Factors contributing to this growth include advancements in the biologics and biosimilars market, rising acceptance of wearable drug delivery systems, expansion of personalized medicine, and improving healthcare reimbursement policies. Other significant driving forces include the integration of digital health technologies, the development of smart and connected devices, advancements in needle-free injection systems, and the emergence of artificial intelligence in device development.

One of the primary growth drivers is the increasing prevalence of diabetes and cardiovascular diseases CVD, propelled by aging populations, unhealthy diets, sedentary lifestyles, obesity, socioeconomic inequalities, stress, environmental factors, and limited access to preventive healthcare. Subcutaneous drug delivery devices, used in diabetes and CVDs to deliver insulin, anticoagulants, or lipid-lowering agents, offer a controlled and convenient method for managing these conditions.

Evidence of this trend includes recently published data by the British Diabetic Association and the Centers for Disease Control and Prevention, highlighting the increasing prevalence of diabetes and heart disease, respectively. Thus, subcutaneous drug delivery devices are expected to play a crucial role in healthcare due to this growing need for simpler and more efficient drug delivery processes.

To learn more and get the full insights, purchase the market report here: https://www.thebusinessresearchcompany.com/report/subcutaneous-drug-delivery-devices-global-market-report

Who Are the Key Market Players in the Subcutaneous Drug Delivery Devices Industry?

Leading companies operating in the subcutaneous drug delivery devices market include Pfizer Inc., Sanofi S.A., Roche Holdings Inc., Medtronic plc, Eli Lilly and Company, Amgen Inc., Novo Nordisk A/S, Becton Dickinson and Company, and others. These market players are investing in innovations to maintain their competitive edge. One instance of such innovation is the development of miniature digital liquid flow sensors by Swiss-based Sensirion AG, which ensure optimal dosing and enhanced patient safety in subcutaneous drug delivery.

How is the Subcutaneous Drug Delivery Devices Market Structured?

The market is broadly divided into:
1 By Product Type: Insulin Pens, Pen Needles, Injector Pens, Auto-Injectors, Implantable Pumps
2 By Application: Diabetes, Fertility, Oncology
3 By End-User: Hospitals And Clinics, Homecare Settings, Ambulatory Surgical Centers

Each of these segments captures a different part of the market, offering inclusive and specific insights into the vast spectrum of devices available.

What is the Global Market Spread in the Subcutaneous Drug Delivery Devices Industry?

North America holds the largest share of the subcutaneous drug delivery devices market as of 2023. However, Asia-Pacific is forecasted to be the fastest-growing region in the market. The report also covers other geographical regions, including Western Europe, Eastern Europe, South America, the Middle East, and Africa.

Browse Through More Similar Reports By The Business Research Company:
Implantable Drug Delivery Devices Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/implantable-drug-delivery-devices-global-market-report
Acne Drugs Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/acne-drugs-global-market-report
Pharmaceutical Drug Delivery Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/pharmaceutical-drug-delivery-global-market-report

About The Business Research Company
Learn More About The Business Research Company. With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

To learn more about our reports, contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
email us here
Visit us on social media:
Facebook
X
LinkedIn